23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Particulate Matter 2.5 Causes Deficiency in Barrier Integrity in Human Nasal Epithelial Cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          The effect of air pollution-related particulate matter (PM) on epithelial barrier function and tight junction (TJ) expression in human nasal mucosa has not been studied to date. This study therefore aimed to assess the direct impact of PM with an aerodynamic diameter less than 2.5 μm (PM2.5) on the barrier function and TJ molecular expression of human nasal epithelial cells.

          Methods

          Air-liquid interface cultures were established with epithelial cells derived from noninflammatory nasal mucosal tissue collected from patients undergoing paranasal sinus surgery. Confluent cultures were exposed to 50 or 100 µg/mL PM2.5 for up to 72 hours, and assessed for 1) epithelial barrier integrity as measured by transepithelial resistance (TER) and permeability of fluorescein isothiocyanate (FITC) 4 kDa; 2) expression of TJs using real-time quantitative polymerase chain reaction and immunofluorescence staining, and 3) proinflammatory cytokines by luminometric bead array or enzyme-linked immunosorbent assay.

          Results

          Compared to control medium, 50 and/or 100 µg/mL PM2.5-treatment 1) significantly decreased TER and increased FITC permeability, which could not be restored by budesonide pretreatment; 2) significantly decreased the expression of claudin-1 messenger RNA, claudin-1, occludin and ZO-1 protein; and 3) significantly increased production of the cytokines interleukin-8, TIMP metallopeptidase inhibitor 1 and thymic stromal lymphopoietin.

          Conclusions

          Exposure to PM2.5 may lead to loss of barrier function in human nasal epithelium through decreased expression of TJ proteins and increased release of proinflammatory cytokines. These results suggest an important mechanism of susceptibility to rhinitis and rhinosinusitis in highly PM2.5-polluted areas.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites.

          There is compelling evidence that epithelial cells (ECs) at mucosal surfaces, beyond their role in creating a physical barrier, are integral components of innate and adaptive immunity. The capacity of these cells to license the functions of specific immune cell populations in the airway and gastrointestinal tract offers the prospect of novel therapeutic strategies to target multiple inflammatory diseases in which barrier immunity is dysregulated. In this review, we discuss the critical functions of EC-derived thymic stromal lymphopoietin (TSLP), interleukin-25 (IL-25), and IL-33 in the development and regulation of T-helper 2 (Th2) cytokine-dependent immune responses. We first highlight recent data that have provided new insights into the factors that control expression of this triad of cytokines and their receptors. In addition, we review their proinflammatory and immunoregulatory functions in models of mucosal infection and inflammation. Lastly, we discuss new findings indicating that despite their diverse structural features and differential expression of their receptors, TSLP, IL-25, and IL-33 cross-regulate one another and share overlapping properties that influence Th2 cytokine-dependent responses at mucosal sites.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Airway Epithelial Barrier Dysfunction in Chronic Obstructive Pulmonary Disease: Role of Cigarette Smoke Exposure

            The epithelial lining of the airway forms the first barrier against environmental insults, such as inhaled cigarette smoke, which is the primary risk factor for the development of chronic obstructive pulmonary disease (COPD). The barrier is formed by airway epithelial junctions, which are interconnected structures that restrict permeability to inhaled pathogens and environmental stressors. Destruction of the epithelial barrier not only exposes subepithelial layers to hazardous agents in the inspired air, but also alters the normal function of epithelial cells, which may eventually contribute to the development of COPD. Of note, disruption of epithelial junctions may lead to modulation of signaling pathways involved in differentiation, repair, and proinflammatory responses. Epithelial barrier dysfunction may be particularly relevant in COPD, where repeated injury by cigarette smoke exposure, pathogens, inflammatory mediators, and impaired epithelial regeneration may compromise the barrier function. In the current review, we discuss recent advances in understanding the mechanisms of barrier dysfunction in COPD, as well as the molecular mechanisms that underlie the impaired repair response of the injured epithelium in COPD and its inability to redifferentiate into a functionally intact epithelium.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found
              Is Open Access

              Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression.

              Tight junction (TJ) defects have recently been associated with asthma and chronic rhinosinusitis. The expression, function, and regulation of nasal epithelial TJs remain unknown in patients with allergic rhinitis (AR).
                Bookmark

                Author and article information

                Journal
                Allergy Asthma Immunol Res
                Allergy Asthma Immunol Res
                AAIR
                Allergy, Asthma & Immunology Research
                The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
                2092-7355
                2092-7363
                January 2020
                30 August 2019
                : 12
                : 1
                : 56-71
                Affiliations
                [1 ]Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China.
                [2 ]Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.
                [3 ]Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
                [4 ]Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland.
                Author notes
                Correspondence to Luo Zhang, MD, PhD. Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, No. 1, DongJiaoMinXiang Street, DongCheng District, Beijing 100730, China. Tel: +86-139-1083-0399; Fax: +86-10-85115988; dr.luozhang@ 123456139.com
                Correspondence to Chengshuo Wang, MD, PhD. Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, No. 1, DongJiaoMinXiang Street, DongCheng District, Beijing 100730, China. Tel: +86-139-1162-3569; Fax: +86-10-85115988; wangcs830@ 123456126.com

                Mu Xian and Siyuan Ma contributed equally to this work.

                Author information
                https://orcid.org/0000-0003-4153-6314
                https://orcid.org/0000-0002-5075-6792
                https://orcid.org/0000-0002-0052-6278
                https://orcid.org/0000-0002-8553-812X
                https://orcid.org/0000-0003-1231-7278
                https://orcid.org/0000-0002-0910-9884
                https://orcid.org/0000-0003-0646-5135
                https://orcid.org/0000-0001-8020-019X
                Article
                10.4168/aair.2020.12.1.56
                6875480
                31743964
                1b35d905-424e-4328-b7c9-d316c4528317
                Copyright © 2020 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 29 June 2019
                : 26 July 2019
                : 29 July 2019
                Funding
                Funded by: National key R&D program of China;
                Award ID: 2016YFC20160905200
                Funded by: The program for the Changjiang scholars and innovative research team;
                Award ID: IRT13082
                Funded by: National Natural Science Foundation of China, CrossRef https://doi.org/10.13039/501100001809;
                Award ID: 81500771
                Award ID: 81470678
                Award ID: 81870698
                Award ID: 81420108009
                Award ID: 81630023
                Funded by: Beijing Municipal Administration of Hospitals, CrossRef https://doi.org/10.13039/501100009601;
                Award ID: SML20150203
                Funded by: Beijing Technology and Business University, CrossRef https://doi.org/10.13039/501100005706;
                Award ID: 20181045
                Funded by: Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support, CrossRef https://doi.org/10.13039/501100009331;
                Award ID: XMLX201816
                Funded by: Capital Health Development Foundation;
                Award ID: 2016-1-2052
                Categories
                Original Article

                Immunology
                epithelial cells,particulate matters,nasal mucosa,rhinitis,asthma,cytokines
                Immunology
                epithelial cells, particulate matters, nasal mucosa, rhinitis, asthma, cytokines

                Comments

                Comment on this article